Member Info for PM2022

Should be the price with 201. Correction.

@Uncanny

The amounts that PYC have stated are matching the amounts stated with just a slight variation of about 10/15k. Note this calculation is based on converting the dollar to pound so when calculated last year when the pound was weaker then a higher amount would have been estimated. This also matches with the fact the total amount PYC claim is slightly higher than the calculated amount and would have been done based on expected payment last year so as it is an ESTIMATE and is a VARIABLE the same amount has been stated again.

Therefore it appears we have had official third party confirmation that 201 will get done this financial year. Everyone seems sure so they must have everything in place. No IFS and no BUTS.

PYC would have been expecting this revenue in the last financial year as 201 was expected to be completed last year. You can't ignore that IT WAS a projected payment that was DUE. This is STILL expected to come through.

Now soon when the 201 deal is announced then we should open around at least 25/30p in the current bear market. That price would be without 201 and the price should quickly move to 40/50p or more depending on if we have 1/2/3 SPV. The issue is due to demand It will most likely be difficult to buy below 35p imo.

A great time to buy and don't forget all this news due soon:

1) Barcelona update due from Feb which will come

2) Hokkaido update from next week

3) Financials showing significant cash reserves

4) Lab contracts- More than one RNS

5) 201 deal/update

6) 301 update

7) World class new compounds coming through for a quick evaluation in our lab. Each one is worth at least 10p moving into SPV and more overtime so huge potential.

8) CLX- significant updates to come.

Note also that if Suzy states they are currently speaking to big pharmas for CLX the price will rocket fast. Therefore the best price to buy is just below 10p so NOW. Honestly I think 5-10 bagger is likely in the next few months alone let alone longer term.

Yes I believe it is 201 but we are in the next financial year from last year so basically this financial year that we are in now. 6% of the total 2 million odd works out at about that sum so Nothing new. They all seem confident it will get done and Suzy said that during the last presentation it will happen this year. Stella also backed it.

201 is not the issue as it's just one compound. The economy is not great but just that we had no real update which appears to be the issue.

I would love to see Barcelona or Hokkaido get into SPV before the AGM and another compound come through. That should be enough to vote them through if they can stop buy and build at these prices.

No cheap placing since options announced last year. The last placing was at the same price as the market price and we would have progressed further with more than 8 RNS due with all valued at almost zero.

The options detailed in the schedule below are exercisable only under market conditions that demonstrate growth in the Company's market capitalisation. Band 1 options vest only after the Company's share price has maintained a 20 Day VWAP (Volume Weight Average Price) of 25p, Band 2 options vest only after the share price has maintained a 20 Day VWAP of 30p and Band 3 Options vest only after the share price has maintained a 20 VWAP of 40p within 2 years of the options being issued. If the price has not reached these price targets by 6 September 2024, the options will lapse; if they meet the criteria, the options can be exercised at any date to 6 September 2032 with an exercise price of 12p

It would be suicidal for BOD to do any placing anywhere near single digits. They do have some decent amount of shares but at these prices they should be buying even more. 400/500k shares each for Suzy and Kevin plus a further 400/500k options. They have just over a year to get these options and got about ten years further to exercise so huge money on offer if they can get this to £1/£2.

They will lose out massively if they do dilutions at the prices Porky mentions. Besides, why would our assets be worth only 5 million pounds at 5p with potentially 2/3 in SPV, lab plus 201. Somehow no chance. More likely of a 25/30p placing than 5p.

They have cash for at least for 1/2 years. I am sure with further progress they will attract large investors and that with the market improving we can easily move to 30/40p in coming months.

The best time anyone could wish to buy this stock is just below 10p so NOW. Wishing for a 5p placing and almost double amount the shares in stupidity and will never happen. The smart ones will buy big at these prices.

Porky pumped DDDD from 80p down to 16p and kept buying all the way down like a spoiled child. The largest shareholder had the sense to sell out. He could read a basic financial report but Porky kept buying thinking it was a bargain and then thought that Oxford FInance would give DDDD 100s millions in loan payments. He listened to what he said and she said rather than reading an RNS and understanding it. How daft. It was not just a wrong call but stupidity on a different level. Clear signs of a COMPLETE NOVICE. NYCT he was shouting £50 but that is now 40p and almost every other stock is always a wrong call with him.

Here he is trying to give us financial advice. What a clown.

Valirx has at least 8 RNS due before the next placing.

1) Barcelona update due from Feb which will come

2) Hokkaido update from next week

3) Financials showing significant cash reserves

4) Lab contracts- More than one RNS

5) 201 deal/update

6) 301 update

7) World class new compounds coming through for a quick evaluation in our lab. Each one is worth at least 10p moving into SPV and more overtime so huge potential.

8) CLX- significant updates to come.

Any one of the above can double us. The market conditions should improve over the next year at some point. All it takes is a few decent buys to move closer to the 20p mark. It appears Valirx has cash until late 2024 and longer with warrants exercised or deal payments.

Key point and call it a freebie but both Kevin and Suzy but have options at 30p/40p and staff also have options around these prices. Suzy and Kevin also have 400/500K shares so I am sure they now need to produce news and time any future placing at the best possible price. I would suggest after lots of news around the 20/25p mark. Doing this at single digits will mean it is unlikely they will reach the target for staff. Therefore staff will not take any future options seriously. They have time.

No real downside from the current SP as CLX is already worth about 20p. All without a lab, evaluation projects, 201, 301. I would say we should be worth 40/50p at the moment so we will rise. Patience required.

THe smart investors would be loading up below 10p knowing the downside is zero over a period of time. I doubt it will ever happen again. This is a huge opportunity to load up.

Would you be happy to buy and know you will likely make at least a 500% return within 12-18 months if all you had to do was wait knowing you had the option to sell at a higher point at any point? Sounds like a plan to me. 10p to 60p not a bad return but personally with a CLX deal i think 100p-200p can be achieved easily.. Be smart DYOR and grab opportunities and avoid listening to losers who will be buying at 50p plus.

We have a gap from last year to this year mainly to cover the running of the lab. The intention is that all the costs for the lab will be covered by revenue by next year.

Therefore we should in theory be burning less cash next year than this year if you minus any revenue once we start getting that as at the moment we are not receiving any revenue.

It matters not. With the amount of news due 0% chance of a placing below the current SP imo.

Here you go again, dragging up 4D Pharma. The CEO lied to Investors, that’s right lied to them in saying they had a 24 mth cash runway because of available loan capital from Oxford Finance when in reality the company was in breach of covenants, the finance got pulled and that’s what led to their rapid demise. But that has sod all to do with Valirx.

This shows me how naive you are Porky. I had one look at the financials and made up my mind that nobody would be financing a company burning about 55 million a year and in debt. The SP was dropping and it was obvious no placing would cover the cash burn rate and the largest shareholder was dumping hard. What were you doing buying the thing. It tells us you have no idea about financials.

The Cenkos report clearly states 700k by the end of 2023 so it takes us around the middle of 2024. With R and D tax credit refund and some lab revenue then end of 2024. By then we could easily have a deal either for CLX or 201.

Your agenda is clear. The more you bang on the less likely it will happen. GIven the amount of news due I would expect a placing at 20p plus when it happens either later this year or next year.

I gave my reasons why we had cash until late 2024/2025.

Given the amount of news due and our very low cash burn rate so what if they need a small placing 1 year from now when we are 20/30p. It doesn't bother me. I like the fact we don't burn huge cash doing clinical trials.

So far the one thing this BOD has done brilliantly is control the finances and keep our cash expenditure low. Not like DDDD burning 55 million a year lol.

Coming from someone who invested in a company burning over 1 million pounds a week with no plan to cover those costs.

Facts are as stated in the Cenkos report 700k at the end of the year. We were burning just over 1 million a year maybe junst over 2 million now.

That takes us to the middle of 2024. BUT we will get significant R AND D tax credit refund, lab contracts by next year which should reduce the cash burn rate and also if we move above 14p another 700k from warrants.

That to me takes us to 2025 fairly easily even without 201. If 201 comes then even better.

All false fears here imo. We are a good buy. Lots of news due, new compounds, Barcelona outcome, Hokkaido outcome, positive financials showing plenty of cash and possible revenue to come and maybe a full update on 301 in the coming weeks.

9 million market cap with about 2 million cash. For us to be valued less the following needs to happen:

Barcelona = failure outcome due

Hokkaido= failure outcome due from next week

301 =failure

401= no deal

201= deal fails despite confidence from Suzy

No new evaluations.

But still with the lab bringing in contracts and CLX we could easily be worth 20-30p in the coming months with another update and much more later. Therefore relative to our current SP the 201 situation does not bother me much.

Best to wait and see what they say during the presentation next month. All this speculation when we don't know the facts is pointless.

The main point is as long as they don't proceed with buy and build which I suspect they have no option but to scale back after resolution 4 and almost 100% shareholders losing money at these prices we will rise significantly at some point.

@Porky because you're not invested so Stella being on BOD with zero shares is a positive for you until she does invest. Those fully invested will see it differently if she continues to hold zero shares. She should ideally invest BEFORE the next placing to ensure she does NOT manipulate the price down for current holders in any potential placing as well as holding back confidence levels.

Warrants are positive. Only 2.5 million so with good news a single individual even without a TR1 can take it all if it was all sold onto the market which it will not be. Good news will get people holding but it will bring more cash, confidence and volume so a positive. We are undervalued anyway so I doubt we will get many sellers below 20p with any decent news.

Not sure what role Stella is playing here. It would be disruptive to get all BOD members fired. What most genuine holders would like to see a pull back from buy and build at these prices or see the BOD back it heavily.

They should make a collective decision to invest before the next placing and we would be ok if they never invested in any placing after it. After the AGM is fine if they announce it during the presentation.

As far as Stella goes she needs to let everyone know whether she intends to invest or not. If she is looking to invest then it is not helpful for her to be on BOD if she does not do it before the next placing but instead is waiting for better prices or to dilute holders first.

Once R and D tax credit refund is calculated and once some lab revenue comes through expect enough cash until 2025.

One of the safer AIM investments with a low cash burn rate as well and plenty of potential.

If you sack the entire BOD then what is left other than assets we hold and why would they stay. This is a small company. Just my opinion but I would rather we agree a way forward than face more disruptions and delays UNLESS Adam becomes CEO.

I agree some changes are needed but ideally if they can publicly put forward plans to grow the SP without low price dilutions (below 20p ) for assets and work in our interests then worth considering otherwise . As I said before the balance is not right which is what caused this problem. They either do not hold enough shares or do not have a major shareholder on the board therefore end up making decisions that are not in our interests. This can easily be rectified.

The less disruption the better unless you plan to wait years with further delays or sell with significant losses at these prices. Everything is in place and this can easily move to multiples with a few tweaks and a bit of news. We shall see in June once news comes out and with future plans in place but they have a chance to clear it all up before then.

1) Start with offering Adam a position and reassure him that he will have a big say in matters and that he will make the final approvals given he owns more than the BOD collectively and understands the business.

2) No further buying below 20 p or until the market conditions improve. Keep control of dilutions for assets and keep the cash burn rate controlled in this market. Explain why any further assets are beneficial for shareholders and why but at the same time making it clear it will not happen at these prices? Back it up by bringing in big buyers as you grow.

3) Collectively buy more shares at these prices BEFORE the AGM.

With the patent issues and lack of data for 201 I can wait if TRX really is the best option. The damage has already been done. We are better off with a deal than without one but an update of some kind would be helpful. Once done at least we have a significant catalyst that would help the SP rise and increase confidence.

Apart from news that is all that is needed and even without much news we can double with this as we should not be 10 p anyway.

Last time BOD was sacked we moved from 3 p to 74 p but we had the biggest catalyst in AIM history in place with phase 2 results for 201 that were to be announced and a market cap of about a million odd. You were going to get that huge rise but we don't quite have that this time so it will take forever if big changes are made.

Great posts BUT worth considering the wider implications.

CLX needs Zai given her outstanding preclinical experience. Val needs Cathy. Both can get jobs instantly and I believe they joined because of Suzy and her vision and may leave if she leaves. Replacements will not be as good and will take a considerable amount of time.

Kevin's buy and build if that is his idea was probably the worst decision that I have come across given the SP and uncertainty that it created. Why tell everyone you want 4 assets then tell them you want a second asset in H1 when the SP is only 10p? Then to not buy any shares and Stella to have zero is not helpful. I agree at higher prices It's a good strategy if done slowly as it attracts large investments but not here.

The best way forward is to offer Adam a flexible position on the board and let him decide. We have the foundations in place and the work done has been good but bad decisions have been made at the wrong time which have impacted the SP. Nobody wants to wait forever. Sometimes the grass is not greener on the other side so careful consideration is needed.

Anyway we still have lots of news due with Barcelona and Hokkaido next month so hopefully we will rise from here.

Suzy was not part of the management team. She was just a scientist and Kevin was also not part of the management team so again another lie.

You invested in a company burning 55 million pounds a year with no sign of a deal or anything to pay 100-200 million upfront cash and when VAL are spending 2-2.5 million you think that is big money. Don't tell me DDDD had so many drugs as you could not work out the basics which took me 10 seconds to figure out. VAL doesn't do clinical trials so a great cost effective strategy.

Porky no biotech can grow with zero scientists. As a company grows the staff numbers also increase. They started with nothing in fact they only had Mark Treharne who was not part of the BOD and is not a scientist. You know this so stop twisting facts.

When a placing happens at such a low market cap you can't raise much. You can't have a market cap of 1 million and raise 5 million this is why I don't think you understand placings and finances. You're the last person I would ever listen to when it comes to finances.

The cash burn has increased as the company has grown but it is still tiny relative to the potential and market cap. Also now they have a lab, quality staff, great strategy to progress high value compounds quickly for huge deals and will soon be generating revenue whilst the cash burn rate is very well controlled.

We only have 100 million shares so by generating revenue we could attract large investment which would make it easier to get to 100, 200p much faster. The only issue is that it should add value for existing holders and by voting no to resolution 4 we made it clear it's not happening at these prices as most holders and in losses. Also Adam does not back it but over time if they do it slowly as the SP grows a decent amount then it's even more likely we hit the £s much faster along with the drug progression.

Risk at the current prices is very low. Maybe 1-2p downside but 100-200p upside over the next 2 years.

Not strictly true. We all know the history and how the old management tried to bankrupt the company. Suzy and her team took over when the market cap was about 0.5 million so had to raise cash from low levels. I agree the true asset value was multiples of that but you can only raise at that market cap at the time.

We only have 100 million shares 3 years later so fairly well managed. I am happy with the financial side of things. Very well managed. Cash until 2024/2025.

As I said 201 is a bonus for me. The new strategy is bang on and I think we will get to 100/200p if we can get another SPV through. That is only a 100 million plus market cap at the moment so easily achieved with one good deal plus 201 and some decent investments.

Not necessarily. Changes would then be needed but that could be getting Adam more involved if he wanted or someone else from the BOD leaving. It all depends but time will tell. All about intentions and effort and if they can show that they want the SP to grow and are making an effort that might make a difference. Obviously the higher the SP the better chance they have.